Hala F M Kamel
Overview
Explore the profile of Hala F M Kamel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
83
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Matboli M, Al-Amodi H, Khaled A, Khaled R, Ali M, Kamel H, et al.
Front Mol Biosci
. 2024 Oct;
11:1430794.
PMID: 39479501
Introduction: Liver cancer, particularly Hepatocellular carcinoma (HCC), remains a significant global health concern due to its high prevalence and heterogeneous nature. Despite the existence of approved drugs for HCC treatment,...
2.
Ahmed I, Kharboush T, Al-Amodi H, Kamel H, Darwish E, Mosbeh A, et al.
Pathogens
. 2024 Oct;
13(10).
PMID: 39452786
Host genetic variation has been recognized as a key predictor of diverse clinical sequelae among severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected patients. Insights into the link between the Interleukin-6...
3.
Ali H, Al-Amodi H, Hamady S, Roushdy M, Hasanin A, Ellithy G, et al.
RSC Med Chem
. 2024 Aug;
15(8):2959.
PMID: 39149107
[This corrects the article DOI: 10.1039/D4MD00023D.].
4.
Matboli M, Al-Amodi H, Hamady S, Ali M, Roushdy M, Hasanin A, et al.
Diabetol Metab Syndr
. 2024 Jul;
16(1):147.
PMID: 38961451
Background: Nonalcoholic fatty pancreatitis (NAFP) presents a pressing challenge within the domain of metabolic disorders, necessitating further exploration to unveil its molecular intricacies and discover effective treatments. Our focus was...
5.
Ali H, Al-Amodi H, Hamady S, Roushdy M, Hasanin A, Ellithy G, et al.
RSC Med Chem
. 2024 Jun;
15(6):2098-2113.
PMID: 38911169
: Inflammation-mediated insulin resistance in type 2 diabetes mellitus (T2DM) increases complications, necessitating investigation of its mechanism to find new safe therapies. This study investigated the effect of rosavin on...
6.
Matboli M, Al-Amodi H, Khaled A, Khaled R, Roushdy M, Ali M, et al.
Front Endocrinol (Lausanne)
. 2024 Jun;
15:1384984.
PMID: 38854687
Introduction: With the increasing prevalence of type 2 diabetes mellitus (T2DM), there is an urgent need to discover effective therapeutic targets for this complex condition. Coding and non-coding RNAs, with...
7.
Abdelsattar S, Fahim S, Kamel H, Al-Amodi H, Kasemy Z, Khalil F, et al.
Noncoding RNA
. 2023 Oct;
9(5).
PMID: 37888208
Ribonucleic acids (RNAs) are important regulators of gene expression and crucial for the progression of hepatocellular carcinoma (HCC). This study was designed to determine the diagnostic and prognostic utility of...
8.
Abdelsattar S, Sweed D, Kamel H, Kasemy Z, Gameel A, Elzohry H, et al.
Biomolecules
. 2023 Jan;
13(1).
PMID: 36671388
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Interestingly, lncRNA-H19 acts independently in HCC and influences miR-675 expressions. We aimed to assess the potential utility of tissue...
9.
Al-Amodi H, Abdelsattar S, Kasemy Z, Bedair H, Elbarbary H, Kamel H
Front Mol Biosci
. 2021 Oct;
8:751299.
PMID: 34692772
Sepsis Associated Kidney Injury represents a major health concern as it is frequently associated with increased risk of mortality and morbidity. We aimed to evaluate the potential value of TNF-α...
10.
Nassir A, Kamel H
Saudi J Biol Sci
. 2020 Jul;
27(8):1975-1984.
PMID: 32714021
Background: Prostate cancer (PCa) is one of the most commonly encountered cancers and the leading cause of death worldwide. Currently used biomarkers accounts difficulties in discriminating benign from malignant cases...